Evidence map›Paper›PMID 39051042›Full record

ReviewAddiction & health2024

The Role of Orexin Receptor Antagonists in Inhibiting Drug Addiction: A Review Article.

Peyman Esmaili-Shahzade-Ali-Akbari, Amir Ghaderi, Atena Sadeghi, Fatemeh Nejat, Alireza Mehramiz

Abstract readReview
In one paragraph

Review in Addiction & health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peyman Esmaili-Shahzade-Ali-AkbariDepartment of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.ORCID https://orcid.org/0000-0002-1811-2700
Amir GhaderiDepartment of Addiction Studies, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Atena SadeghiDepartment of Microbiology, Faculty of Medicine, Shahed University, Tehran, Iran.
Fatemeh NejatDepartment of Biology and Health Sciences, Meredith College, Raleigh, North Carolina, USA.ORCID https://orcid.org/0009-0001-2820-1504
Alireza MehramizDepartment of Physical Therapy, Faculty of Paramedical and Rehabilitation Science, Mashhad University of Medical Sciences, Mashhad, Iran.ORCID https://orcid.org/0009-0005-3648-6692

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The orexinergic system and its receptors are involved in many physiological processes. Their functions in energy homeostasis, arousal, cognition, stress processing, endocrine functions, and pain modulation have been investigated. Many studies have shown that the orexinergic system cooperates with the dopaminergic system in the addiction process. Emerging evidence suggests that the orexinergic system can be effective in the induction of drug dependence and tolerance. Therefore, several researches have been conducted on the effect of orexin receptor (OXR) antagonists on reducing tolerance and dependence caused by drug abuse. Due to the significant growth of the studies on the orexinergic system, the current literature was conducted to collect the findings of previous studies on orexin and its receptors in the induction of drug addiction. In addition, cellular and molecular mechanisms of the possible role of orexin in drug tolerance and dependence are discussed. The findings indicate that the administration of OXR antagonists reduces drug dependence. OXR blockers seem to counteract the addictive effects of drugs through multiple mechanisms, such as preventing neuronal adaptation. This review proposes the potential clinical use of OXR antagonists in the treatment of drug dependence.

Indexed as

AddictionDependenceHypocretinOrexinToleranceWithdrawal

Identifiers

PMID39051042
PMCPMC11264478

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.